LGALS9 (galectin-9) acts as the ligand for the T cell immunoglobulin domain and mucin domain-3 on CD4+ T cell surface, thereby leading to T cell apoptosis and poor prognosis in glioblastoma [84]. This evidence concerns the gene LGALS9 and glioblastoma.